Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Parkinson's Disease Dementia or Dementia With Lewy Bodies
NCT00630500Phase 2Completed
- Sponsor
- Stavanger University Hospital
- Start
- Feb 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of memantine in Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), sponsored by Stavanger University Hospital. Primary endpoint: Clinical Global Impression of Change at 6 months. Started Feb 2006; status: completed.
02
Drugs
memantine
03
Conditions
Parkinson's disease dementia (PDD)dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT00630500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630500.